Immunotherapy for Kidney Cancer: Advancing Treatments at a Leading Cancer Center
Official title: Engaging Impactful Immunotherapy Approaches in Renal Cell Cancer Studies
Funded at University of Pennsylvania · NIH-11397822 · Data updated 2026-11-12
A cancer center is testing new immunotherapy approaches for kidney cancer to improve patients’ responses and survival.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 1, 2025 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $178,893 |
| NIH project number | 5R50CA288482-02 |
| Project ID | NIH-11397822 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with renal cell cancer who are candidates for immunotherapy trials or translational biomarker studies at participating centers.
✕Less likely to help
Patients not eligible for immunotherapy trials or without biomarker-driven treatment options may not directly benefit.
What this research studies
This grant supports developing and coordinating immunotherapy trials for renal cell cancer at the Abramson Cancer Center, connecting clinicians with translational scientists to use biomarkers and immune signals to guide treatments. The work will bring promising RCC immunotherapies to larger national networks and potentially to clinical trials through ECOG-ACRIN and the NCTN. It builds on real patient data, biomarker studies, and collaboration to tailor therapies and to study how T cell features and chromatin patterns relate to outcomes after checkpoint inhibitors. The aim is to create more effective, personalized immunotherapy options for people with RCC, including exploring consolidation strategies after deep responses.
Why it matters
Potential benefit: If successful, patients with RCC could have access to more effective immunotherapies and clearer, biomarker-guided treatment paths.
How similar studies have gone: There is ongoing translational work linking T cell phenotypes and chromatin signals to responses in RCC immunotherapy, with some promising signals in early studies.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Haas, Naomi B — University of Pennsylvania
- Study coordinator: Haas, Naomi B
Related research
Other NIH-funded projects on the same topics.
-
Boosting immune response to fight cancer
This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.
-
A center focused on immunotherapy for pediatric cancers.
This study is exploring new ways to use the body's immune system to fight childhood cancers, aiming to create better treatments for kids whose cancers haven't responded well to standard therapies.
-
Algorithms to find HLA-E neoantigens for cancer immunotherapy
Aims to develop computer methods to discover tumor-specific targets presented by HLA-E to guide new T cell therapies for cancer.
-
Immunotherapy for glioblastoma: advancing treatment and understanding
A patient-friendly summary of a grant exploring new immune-based treatments for glioblastoma to improve options for people affected by this brain cancer.
-
How CRISPR-based gene activation could shape immunotherapy responses in clear cell cancers
A research project at Stanford is using CRISPR-based gene activation to understand why some clear cell ovarian and kidney cancers respond to immunotherapy while others do not.
-
Hybrid biomaterial system to boost immunotherapy for rheumatoid arthritis
A new, patient-facing immunotherapy approach uses specialized particles to retrain the immune system to calm RA in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.